CRISPR Therapeutics AG (CRSP)
68.15
-2.01
(-2.86%)
USD |
NASDAQ |
Mar 28, 16:00
68.27
+0.12
(+0.18%)
After-Hours: 19:29
CRISPR Therapeutics Total Return Level: 70.16 for March 27, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
March 27, 2024 | 70.16 |
March 26, 2024 | 70.97 |
March 25, 2024 | 71.08 |
March 22, 2024 | 71.61 |
March 21, 2024 | 74.50 |
March 20, 2024 | 72.94 |
March 19, 2024 | 71.96 |
March 18, 2024 | 71.47 |
March 15, 2024 | 72.95 |
March 14, 2024 | 72.01 |
March 13, 2024 | 74.78 |
March 12, 2024 | 75.30 |
March 11, 2024 | 76.82 |
March 08, 2024 | 78.92 |
March 07, 2024 | 79.37 |
March 06, 2024 | 80.83 |
March 05, 2024 | 80.99 |
March 04, 2024 | 81.74 |
March 01, 2024 | 83.75 |
February 29, 2024 | 84.22 |
February 28, 2024 | 87.68 |
February 27, 2024 | 89.12 |
February 26, 2024 | 86.06 |
February 23, 2024 | 83.99 |
February 22, 2024 | 86.19 |
Date | Value |
---|---|
February 21, 2024 | 82.41 |
February 20, 2024 | 78.73 |
February 16, 2024 | 82.22 |
February 15, 2024 | 84.48 |
February 14, 2024 | 79.04 |
February 13, 2024 | 72.78 |
February 12, 2024 | 76.44 |
February 09, 2024 | 70.01 |
February 08, 2024 | 68.83 |
February 07, 2024 | 65.72 |
February 06, 2024 | 66.88 |
February 05, 2024 | 64.51 |
February 02, 2024 | 64.75 |
February 01, 2024 | 64.67 |
January 31, 2024 | 62.95 |
January 30, 2024 | 64.48 |
January 29, 2024 | 65.78 |
January 26, 2024 | 61.01 |
January 25, 2024 | 62.87 |
January 24, 2024 | 63.01 |
January 23, 2024 | 66.19 |
January 22, 2024 | 65.26 |
January 19, 2024 | 61.99 |
January 18, 2024 | 60.98 |
January 17, 2024 | 60.86 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
33.68
Minimum
Mar 16 2020
210.04
Maximum
Jan 14 2021
73.74
Average
62.95
Median
Jan 31 2024
Total Return Level Benchmarks
Vertex Pharmaceuticals Inc | 417.50 |
Intellia Therapeutics Inc | 27.00 |
Roche Holding AG | 61.14 |
Novartis AG | 200.54 |
bluebird bio Inc | 1.365 |